Efficacy and Safety of VDPHL01 in Males With AGA

Clinical trial NCT06724614 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06724614
Sponsor: Veradermics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Androgenetic Alopecia AGA Male Pattern Baldness

Start date: 2024-11-06
Primary completion: 2026-02-01
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.